Hopfield Neural Network for the segmentation of Near Infrared Fluorescent images for diagnosing prostate cancer
暂无分享,去创建一个
[1] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[2] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[3] James P Basilion,et al. Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer , 2014, Molecular Cancer Therapeutics.
[4] Jianlin Yuan,et al. Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field , 2014, International journal of nanomedicine.
[5] George L. Wright,et al. Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids , 1995, International journal of cancer.
[6] Martin G Pomper,et al. 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. , 2010, Journal of medicinal chemistry.
[7] Zhenghong Lee,et al. Targeted treatment of prostate cancer , 2007, Journal of cellular biochemistry.
[8] Alexander L. Vahrmeijer,et al. Optical Image-guided Surgery—Where Do We Stand? , 2010, Molecular Imaging and Biology.
[9] Dongfeng Pan,et al. Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer , 2013, Translational andrology and urology.
[10] M. Sadelain,et al. A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy? , 2001, Critical reviews in immunology.
[11] P. Low,et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.
[12] Peter L. Choyke,et al. Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe , 2011, Science Translational Medicine.
[13] G. Prendergast. Molecular cancer therapeutics : strategies for drug discovery and development , 2005 .
[14] Andrew E. Sloan,et al. Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue , 2012, PloS one.
[15] Yue Wang,et al. A Modified Deterministic Annealing Algorithm for Robust Image Segmentation , 2008, Journal of Mathematical Imaging and Vision.
[16] Rachid Sammouda,et al. Agriculture satellite image segmentation using a modified artificial Hopfield neural network , 2014, Comput. Hum. Behav..
[17] Ralph Weissleder,et al. Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.
[18] Kinneret Keren,et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.
[19] A. Deblasio,et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.
[20] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[21] Slave Trajanoski,et al. Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis , 2009, Pathology & Oncology Research.
[22] Prabhjot Kaur,et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] Martin G Pomper,et al. A low molecular weight PSMA-based fluorescent imaging agent for cancer. , 2009, Biochemical and biophysical research communications.
[24] Nina M. Muñoz,et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.
[25] Sabrina S Wilson. Radiology , 1938, Glasgow Medical Journal.
[26] Xavier Llorà,et al. Towards better than human capability in diagnosing prostate cancer using infrared spectroscopic imaging , 2007, GECCO '07.
[27] Michael E. Phelps,et al. Molecular Imaging and Biology , 2003 .